---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-003847"
form_type: "8-K"
ticker: "GRCE"
cik: "0001444192"
company_name: "Grace Therapeutics, Inc."
filed_at: "2023-02-23T23:59:59+00:00"
generated_at: "2026-06-19T02:23:18.368942+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Acasti Pharma dismisses KPMG as auditor, appoints Ernst & Young

## Summary
- Audit committee and board approved dismissal of KPMG on February 22, 2023.
- KPMG's reports for fiscal years ended March 31, 2022 and 2021 were unqualified with no adverse opinions.
- No disagreements or reportable events occurred between the company and KPMG during the relevant periods.
- Board approved engagement of Ernst & Young LLP as new independent auditor for fiscal year ending March 31, 2023.
- KPMG furnished a letter to the SEC agreeing with the company's disclosures.

## SEC filing metadata
- accession: 0000950170-23-003847
- form_type: 8-K
- ticker: GRCE
- cik: 0001444192
- company_name: Grace Therapeutics, Inc.
- filed_at: 2023-02-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1444192/000095017023003847/0000950170-23-003847-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1444192/000095017023003847/acst-20230222.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-003847
- JSON: https://secwatch.observer/filing/0000950170-23-003847.json
- Plain text: https://secwatch.observer/filing/0000950170-23-003847.txt

## Key facts
- Auditor Changes
  Grace Therapeutics, Inc. engaged Ernst & Young LLP as its auditor.
  - Action: engagement
  - Auditor: Ernst & Young LLP
  source text: On February 22, 2023, in connection with the Company’s dismissal of KPMG, the Board approved the engagement of Ernst & Young LLP (“E&Y”) as its new independent registered public accounting firm to audit the Company’s financial statements for the fiscal year ending March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1444192/000095017023003847/0000950170-23-003847-index.htm
- Auditor Changes
  Grace Therapeutics, Inc. dismissed KPMG LLP as its auditor.
  - Action: dismissal
  - Auditor: KPMG LLP
  - Successor: Ernst & Young LLP
  source text: On February 22, 2023, the audit committee and board of directors (the “Board”) of the Company approved the dismissal of KPMG as the Company’s independent registered public accounting firm.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1444192/000095017023003847/0000950170-23-003847-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.